Icecure Medical is trading up 5.66% in pre-market at $1.12, with the immediate catalyst unclear. - The price compares with its October 16 close of $1.06. - Its latest highlighted clinical data and physician engagement at EUSOBI were announced October 13, prior context rather than a clear new catalyst. - Major U.S. indexes were higher amid recent technology weakness, but the supplied market context does not establish a broad-market reason for the move.